Cell-Specific Regulation of Inflammatory Cytokines and Acute-Phase Proteins by the Glucocorticoid Receptor

Rebecca Winkler1, Hong Lu1

  • 1Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Mediators of Inflammation
|December 2, 2024
PubMed
Abstract

Insights

Glucocorticoid receptor (GR) differentially regulates chemokine expression in liver cells, inhibiting CXCL1 and CXCL8 while having cell-specific effects on CXCL2. This suggests potential therapeutic strategies for inflammatory liver diseases by modulating GR activity.

Area of Science:

  • Molecular biology
  • Immunology
  • Hepatology

Background:

  • Inflammatory liver diseases are associated with altered chemokine expression, including increased CXCL1 and CXCL8 and decreased CXCL2.
  • The role of the glucocorticoid receptor (GR) in modulating chemokine and acute-phase protein expression in the liver during infection or inflammation is not fully understood.

Purpose of the Study:

  • To investigate the effects of the glucocorticoid receptor (GR) on chemokine expression in human liver cells.
  • To understand how GR influences CXCL1, CXCL2, and CXCL8 expression in response to inflammatory stimuli like lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNFα).

Main Methods:

  • Primary human hepatocytes (PHH) were treated with TNFα, LPS, and dexamethasone (DEX).
  • Chemokine mRNA and protein levels were quantified using qPCR and ELISA.
  • Dual luciferase assays with wild-type and mutant CXCL2 promoters in various cell lines (HEK293T, HEPG2) were used to identify GR-responsive regions.

Main Results:

  • GR exhibited cell-specific effects: it inhibited CXCL1 and CXCL8 in PHH and HEK293T cells but showed varied effects on CXCL2.
  • In hepatocytes (PHH, HEPG2), GR activity influenced CXCL2 promoter activity differently compared to non-hepatic cells (HEK293T).
  • A specific 407-bp region of the CXCL2 promoter was crucial for GR activity in HEPG2 cells, with TNFα synergizing with HNF4α.

Conclusions:

  • GR's impact on chemokine expression is both cell-type and chemokine-specific.
  • The differential regulation of CXCL2 by GR in hepatocytes versus non-hepatocytes is mediated by cell-specific promoter utilization.
  • Targeting GR in the liver may offer a strategy to correct chemokine imbalances and mitigate sepsis in inflammatory liver conditions.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
951
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K